e-ISSN: Pending
Failure-mode index

Search what already failed

A searchable index of real negative results, null findings, and replication failures from the published literature — so you can learn what didn't work before repeating it.

WASTE indexes published research — it does not host or republish full papers. Each entry is a metadata record (title, authors, DOI) compiled from open scholarly databases, with the abstract shown in full only where the paper is openly licensed (e.g. Creative Commons); otherwise a short excerpt is shown for reference under fair use. WASTE classifies each work by failure type; classifications are automated and approximate.

14 results in Negative / Null Result Report for "CRISPR"

Negative / Null Result ReportOpen accessBiochemistry, Genetics and Molecular Biology

Complete loss of ATM function augments replication catastrophe induced by ATR inhibition and gemcitabine in pancreatic cancer models

Charles R. Dunlop, Yann Wallez, Timothy Isaac Johnson et al. · 2020 · British Journal of Cancer

BACKGROUND: Personalised medicine strategies may improve outcomes in pancreatic ductal adenocarcinoma (PDAC), but validation of predictive biomarkers is required. Having developed a clinical trial to assess the ATR inhibitor, AZD6738, in combination with gemcitabine (ATRi/gem), we investigated ATM loss as a predictive biomarker of response to ATRi/gem in PDAC. METHODS: Through kinase inhibition, siRNA depletion and CRISPR knockout of ATM, we assessed how ATM targeting affected the sensitivity of PDAC cells to ATRi/gem. Using flow cytometry, immunofluorescence and immunoblotting, we investigate

View details →DOI: 10.1038/s41416-020-1016-2Cited by 63
Negative / Null Result ReportOpen accessBiochemistry, Genetics and Molecular Biology

CRISPR–Cas technologies in neurodegenerative disorders: mechanistic insights, therapeutic potential, and translational challenges

Raya Kh. Yashooa, Ari Q. Nabi, Shukur Wasman Smail et al. · 2026 · Frontiers in Neurology

CRISPR-Cas genome-editing technologies have emerged as powerful tools for precise DNA and RNA modulation, offering promising therapeutic strategies for neurodegenerative disorders such as Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), and amyotrophic lateral sclerosis (ALS). This review critically evaluates current CRISPR/Cas applications in neurodegeneration, with emphasis on mechanistic insights, therapeutic outcomes, and translational feasibility. Preclinical and early translational studies demonstrate that CRISPR-Cas platforms can correct pathogenic mutation

View details →DOI: 10.3389/fneur.2025.1737468Cited by 13
Negative / Null Result ReportOpen accessAgricultural and Biological Sciences

Integrative Genomics and Precision Breeding for Stress-Resilient Cotton: Recent Advances and Prospects

Zahra Ghorbanzadeh, Bahman Panahi, Leila Purhang et al. · 2025 · Agronomy

Developing climate-resilient and high-quality cotton cultivars remains an urgent challenge, as the key target traits yield, fibre properties, and stress tolerance are highly polygenic and strongly influenced by genotype–environment interactions. Recent advances in chromosome-scale genome assemblies, pan-genomics, and haplotype-resolved resequencing have greatly enhanced the capacity to identify causal variants and recover non-reference alleles linked to fibre development and environmental adaptation. Parallel progress in functional genomics and precision genome editing, particularly CRISPR/Cas

View details →DOI: 10.3390/agronomy15102393Cited by 10
Negative / Null Result Report

Discovery of Tcf7 regulators with clonally-resolved CRISPR screens identifies Trim28 as a mediator of CD8 T cell differentiation in tumors

Schwartz MA, Lue D, Mutaher M et al. · 2026 · Preprint

Stem-like TCF7+ CD8 T cells sustain anti-tumor responses and support immune checkpoint blockade. We systematically identified regulators of this cell state using genome-wide CRISPR screens in primary T cells in vitro . Using random…

View details →DOI: 10.64898/2026.06.14.732162
Negative / Null Result ReportMedicine

Correcting photoreceptor diseases at their source: CRISPR strategies for cone-rod dystrophy and achromatopsia.

Zaki HF, Bishri J, Abdul Muqtadir M et al. · 2026 · Experimental eye research

Background Cone-rod dystrophy (CORD) and achromatopsia (ACHM) are inherited retinal dystrophies for which conventional adeno-associated virus (AAV) gene augmentation has important limitations, particularly in autosomal-dominant…

View details →DOI: 10.1016/j.exer.2026.111119
Negative / Null Result ReportOpen accessVeterinary medicine

Influence of Electroporation Timing on CRISPR/Cas-Mediated Multiple Gene Editing in Buffalo Embryos

Dipankar Sardar, Md. Taslim Hossain, Rudranil Baidya et al. · 2024 · Veterinary Integrative Sciences

Gene editing in large animals like buffalo is challenged by mosaicism, where cells contain both wild-type and mutant alleles, complicating the creation of genetically modified F0 animals in a single step. Traditionally, electroporation is performed on zygotes post in vitro fertilization (IVF), but mature oocytes’ higher permeability suggests earlier intervention might reduce mosaicism and enhance editing efficiency. We hypothesized that the timing of electroporation before in vitro fertilization (IVF) can increase the rates of biallelic mutation for multiple gene knockout as the permeability o

View details →DOI: 10.12982/vis.2025.069
Negative / Null Result ReportOpen accessMedicine

Occurrence of CRISPR-Cas genes and lack of association with antibiotic resistance in Shigella isolates collected from patients with diarrhea in Ahvaz, southwest Iran.

Ekrami A, Taheri B, Daneshfar S et al. · 2025 · BMC infectious diseases

BACKGROUND: So far, few studies have examined the association between CRISPR-Cas and antibiotic resistance in Shigella isolates. Hence, this study sought to address this issue in Shigella species isolated from stool samples of patients…

View details →DOI: 10.1186/s12879-025-12100-0
Negative / Null Result Report

Turnip mosaic virus-based gRNA delivery system for plant genome editing

Khwanbua E, Lappe RR, Bierl AA et al. · 2026 · Preprint

Plant virus-based gRNA delivery systems offer a rapid alternative to stable transformation for CRISPR-mediated genome editing, but potyvirus-based platforms in Cas9-expressing plants are still underexplored. Here, we developed a turnip…

View details →DOI: 10.64898/2026.04.22.720221
Negative / Null Result ReportMedicine

CRISPR/Cas9-Mediated Knockout of the NAD-Dependent Lactate Dehydrogenases for Altered Stereospecific Lactic Acid Production in Lacticaseibacillus paracasei NC4.

Chu NH, Le HD, Quach NT et al. · 2026 · Biochemical genetics

The optical purity of lactic acid is a critical parameter for producing high-performance polylactic acid (PLA). To investigate the genetic basis of stereospecific lactic acid biosynthesis, the present study aimed to functionally…

View details →DOI: 10.1007/s10528-026-11374-6
Negative / Null Result ReportOpen accessMedicine

AcrIIA8 is a putative phage structural protein of the HTJ2 family that does not inhibit Streptococcus pyogenes Cas9.

An SY, Kim I, Hong SH et al. · 2026 · Protein science : a publication of the Protein Society

Anti-CRISPR (Acr) proteins are phage-encoded anti-defense factors that suppress CRISPR-Cas immunity in bacteria. AcrIIA8 was previously identified as an inhibitor of Streptococcus pyogenes Cas9 (SpyCas9) through functional assays of…

View details →DOI: 10.1002/pro.70651